Neal James R Insider Trades

Insider Trading History

Track insider trading activity for Neal James R. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Director
Holding Value $2.25k 818 shares
Last Trade
Mar 31, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2k 789 shares
$2.54
$2.75
Akari Therapeutics Plc
Akari Therapeutics Plc AKTX
Director
Holding Value $49k 3,093 shares
Last Trade
Dec 16, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$113k 11,132 shares
$10.14
$15.84
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Director
Holding Value $825k 300,000 shares
Last Trade
Oct 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$60k 300,000 shares
$0.20
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Director
Holding Value $568k 206,505 shares
Last Trade
Jul 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44k 175,299 shares
$0.25
$2.75
Akari Therapeutics Plc
Akari Therapeutics Plc AKTX
Director
Holding Value $3.56M 225,000 shares
Last Trade
Mar 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$600k 400,000 shares
$1.50
$15.84
Akari Therapeutics Plc
Akari Therapeutics Plc AKTX
Director
Holding Value $575k 36,271 shares
Last Trade
Mar 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$486k 13,392 shares
$36.26
$15.84
Akari Therapeutics Plc
Akari Therapeutics Plc AKTX
Director
Holding Value $510M 32,216,000 shares
Last Trade
Jan 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.2M 8,000,000 shares
$1.28
$15.84
Akari Therapeutics Plc
Akari Therapeutics Plc AKTX
Director
Holding Value $384M 24,216,000 shares
Last Trade
Dec 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.9M 2,000,000 shares
$0.95
$15.84
Peak Bio
Peak Bio PKBO
Director
Holding Value $0 0 shares
Last Trade
Nov 14, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$12.3k 533,340 shares
$0.02
$0.02
Akari Therapeutics Plc
Akari Therapeutics Plc AKTX
Director
Holding Value $352M 22,216,000 shares
Last Trade
Nov 14, 2024 Sale
$27.9B 313,070,000 shares
$89.20
$15.84
Peak Bio- Warrants (05/01/2026)
Peak Bio- Warrants (05/01/2026) PKBOW
Director
Holding Value $0 0 shares
Last Trade
Nov 14, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5.28k 533,340 shares
$0.01
$0.01
Peak Bio- Warrants (05/01/2026)
Peak Bio- Warrants (05/01/2026) PKBOW
Director
Holding Value $375 37,850 shares
Last Trade
Nov 14, 2024 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$375 37,850 shares
$0.01
$0.01
Peak Bio
Peak Bio PKBO
Director
Holding Value $852 37,850 shares
Last Trade
Nov 14, 2024 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$871 37,850 shares
$0.02
$0.02
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Director
Holding Value $85.8k 31,206 shares
Last Trade
Sep 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44k 31,206 shares
$1.41
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Director
Holding Value $99.8k 36,275 shares
Last Trade
Sep 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44k 31,206 shares
$1.41
$2.75
Palisade Bio
Palisade Bio PALI
Director
Holding Value $0 0 shares
Last Trade
Feb 09, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.38k 19,040 shares
$0.44
$1.93
Palisade Bio
Palisade Bio PALI
Director
Holding Value $23.5k 12,160 shares
Last Trade
Feb 09, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.38k 19,040 shares
$0.44
$1.93
Palisade Bio
Palisade Bio PALI
Director
Holding Value $13.3k 6,880 shares
Last Trade
Nov 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.06k 6,880 shares
$0.59
$1.93
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Director
Holding Value $279k 101,365 shares
Last Trade
Jun 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26M 101,365 shares
$256.50
$2.75
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Director
Holding Value $39.6k 14,407 shares
Last Trade
Jun 27, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.7M 14,407 shares
$256.50
$2.75

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up